Behcet's ileocolitis: Successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy - Report of a case

被引：51
|
作者：
Kram, MT [1 ]
May, LD [1 ]
Goodman, S [1 ]
Molinas, S [1 ]
机构：
[1] Nyack Hosp, Dept Gastroenterol, Nyack, NY USA
来源：
DISEASES OF THE COLON & RECTUM | 2003年 / 46卷 / 01期
关键词：
antibodies; monoclonal/therapeutic use; Behcet's syndrome; Behcet's syndrome/diagnosis; Behcet's syndrome/drug therapy; Behcet's syndrome/pathology; Behcet's syndrome/surgery; tumor necrosis factor;
D O I：
10.1007/s10350-004-6506-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Behcet's disease is a chronic inflammatory disease characterized by recurrent oral aphthae and systemic manifestations. Gastrointestinal involvement is rare. We report a case of ileocolitis secondary to Behcet's successfully treated with tumor necrosis factor-alpha antibody (infliximab) therapy. To our knowledge this is the second reported case of Behcet's ileocolitis successfully treated with anti-tumor necrosis factor therapy.
引用
收藏
页码：118 / 121
页数：4
相关论文
共 50 条
  • [1] Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
    Baert, FJ
    D'Haens, GR
    Peeters, M
    Hiele, MI
    Schaible, TF
    Shealy, D
    Geboes, K
    Rutgeerts, PJ
    GASTROENTEROLOGY, 1999, 116 (01) : 22 - 28
  • [2] Tocilizumab for the Treatment of Behcet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy
    Ozturk, Hilal Eser
    Oray, Merih
    Tugal-Tutkun, Ilknur
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (07) : 1005 - 1014
  • [3] Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody)
    Burt, MJ
    Frizelle, FA
    Barbezat, GO
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (04) : 465 - U3
  • [4] Anti-tumor necrosis factor-alpha therapy with the chimeric monoclonal antibody infliximab in severe undifferentiated spondyloarthropathy
    Schnarr, S
    Huelsemann, JL
    Merkesdal, S
    Brandt, J
    Braun, J
    Prudlo-Winkler, S
    Zeidler, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 422 - 422
  • [5] Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
    Salvatore Gulli
    Carlo Arrigo
    Loredana Bocchino
    Lucia Morgante
    Donatella Sangari
    Irene Castagna
    Gian Filippo Bagnato
    BMC Musculoskeletal Disorders, 4
  • [6] Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: A case report
    Hassard, PV
    Binder, SW
    Nelson, V
    Vasiliauskas, EA
    GASTROENTEROLOGY, 2001, 120 (04) : 995 - 999
  • [7] Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
    Gulli, S
    Arrigo, C
    Bocchino, L
    Morgante, L
    Sangari, D
    Castagna, I
    Bagnato, GF
    BMC MUSCULOSKELETAL DISORDERS, 2003, 4 (1)
  • [8] A case report: Ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis
    Kinnunen, Urpo
    Farkkila, Martti
    Makisalo, Heikki
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (06): : 724 - 727
  • [9] Anti-Tumor Necrosis Factor-alpha in therapy of severe alcoholic hepatitis: a case report
    Romano, M.
    Fierro, A.
    Moscatelli, R.
    D'Amore, F.
    ITALIAN JOURNAL OF MEDICINE, 2007, 1 (04) : 25 - 31
  • [10] Tumor necrosis factor-alpha antibody for maintenace of remission in Crohn's disease
    Behm, B. W.
    Bickston, S. J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
12345